CONSOLIDATED INCOME STATEMENT - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Income Statement [Abstract]
Revenues	$ 594,781	$ 571,414
Cost of service, inclusive of depreciation	334,050	321,537
General and administrative expenses:
Salaries and benefits	131,968	127,946
Non-cash compensation	6,223	7,433
Merger-related expenses	16,769	20,667
Depreciation and amortization	4,447	4,271
Other	57,965	57,941
Total operating expenses	551,422	539,795
Operating income	43,359	31,619
Other income (expense):
Interest income	2,873	1,727
Interest expense	6,422	8,119
Equity in earnings from equity method investments	1,794	910
Gain on equity method investment	48,093	0
Miscellaneous, net	1,508	1,090
Total other income (expense), net	47,846	(4,392)
Income before income taxes	91,205	27,227
Income tax expense	(29,384)	(12,633)
Net income	61,821	14,594
Net income attributable to noncontrolling interests	(809)	(194)
Net income attributable to Amedisys, Inc.	$ 61,012	$ 14,400
Basic earnings per common share:
Net income attributable to Amedisys, Inc. common stockholders	$ 1.86	$ 0.44
Weighted average shares outstanding, basic (shares)	32,793	32,670
Diluted earnings per common share:
Net income attributable to Amedisys, Inc. common stockholders	$ 1.84	$ 0.44
Weighted average shares outstanding, diluted (shares)	33,218	32,979